Get Premium to unlock powerful stock data

Tri Locum Partners LP Buys Baxter International Inc, Seagen Inc, Merck Inc, Sells Regeneron Pharmaceuticals Inc, Jazz Pharmaceuticals PLC, Protagonist Therapeutics Inc

Author's Avatar
insider
Nov 16, 2021
Article's Main Image
Investment company Tri Locum Partners LP (Current Portfolio) buys Baxter International Inc, Seagen Inc, Merck Inc, The Beauty Health Co, Sarepta Therapeutics Inc, sells Regeneron Pharmaceuticals Inc, Jazz Pharmaceuticals PLC, Protagonist Therapeutics Inc, Johnson & Johnson, Cigna Corp during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Tri Locum Partners LP. As of 2021Q3, Tri Locum Partners LP owns 28 stocks with a total value of $252 million. These are the details of the buys and sells.

For the details of Tri Locum Partners LP's stock buys and sells, go to https://www.gurufocus.com/guru/tri+locum+partners+lp/current-portfolio/portfolio

These are the top 5 holdings of Tri Locum Partners LP
  1. Horizon Therapeutics PLC (HZNP) - 261,500 shares, 11.38% of the total portfolio. Shares added by 1.45%
  2. Baxter International Inc (BAX) - 312,400 shares, 9.98% of the total portfolio. New Position
  3. Walgreens Boots Alliance Inc (WBA) - 350,000 shares, 6.54% of the total portfolio.
  4. Seagen Inc (SGEN) - 96,307 shares, 6.50% of the total portfolio. New Position
  5. Walgreens Boots Alliance Inc (WBA) - 312,847 shares, 5.85% of the total portfolio. Shares reduced by 26.5%
New Purchase: Baxter International Inc (BAX)

Tri Locum Partners LP initiated holding in Baxter International Inc. The purchase prices were between $73.77 and $83.61, with an estimated average price of $79.12. The stock is now traded at around $79.510000. The impact to a portfolio due to this purchase was 9.98%. The holding were 312,400 shares as of 2021-09-30.

New Purchase: Seagen Inc (SGEN)

Tri Locum Partners LP initiated holding in Seagen Inc. The purchase prices were between $142.45 and $169.82, with an estimated average price of $155.61. The stock is now traded at around $179.590000. The impact to a portfolio due to this purchase was 6.5%. The holding were 96,307 shares as of 2021-09-30.

New Purchase: Merck & Co Inc (MRK)

Tri Locum Partners LP initiated holding in Merck & Co Inc. The purchase prices were between $71.68 and $78.83, with an estimated average price of $76.11. The stock is now traded at around $84.180000. The impact to a portfolio due to this purchase was 5.43%. The holding were 181,765 shares as of 2021-09-30.

New Purchase: The Beauty Health Co (SKIN)

Tri Locum Partners LP initiated holding in The Beauty Health Co. The purchase prices were between $16.76 and $28.26, with an estimated average price of $22.02. The stock is now traded at around $26.840000. The impact to a portfolio due to this purchase was 5.21%. The holding were 504,606 shares as of 2021-09-30.

New Purchase: Sarepta Therapeutics Inc (SRPT)

Tri Locum Partners LP initiated holding in Sarepta Therapeutics Inc. The purchase prices were between $65.97 and $92.48, with an estimated average price of $77.05. The stock is now traded at around $83.520000. The impact to a portfolio due to this purchase was 4.96%. The holding were 135,055 shares as of 2021-09-30.

New Purchase: Legend Biotech Corp (LEGN)

Tri Locum Partners LP initiated holding in Legend Biotech Corp. The purchase prices were between $35.31 and $50.56, with an estimated average price of $41.56. The stock is now traded at around $54.420000. The impact to a portfolio due to this purchase was 3.38%. The holding were 168,467 shares as of 2021-09-30.

Added: Edwards Lifesciences Corp (EW)

Tri Locum Partners LP added to a holding in Edwards Lifesciences Corp by 154.58%. The purchase prices were between $102.91 and $122.75, with an estimated average price of $114.13. The stock is now traded at around $117.370000. The impact to a portfolio due to this purchase was 3.36%. The holding were 122,880 shares as of 2021-09-30.

Added: IVERIC bio Inc (ISEE)

Tri Locum Partners LP added to a holding in IVERIC bio Inc by 290.11%. The purchase prices were between $7.07 and $17.5, with an estimated average price of $10.82. The stock is now traded at around $16.455000. The impact to a portfolio due to this purchase was 1.81%. The holding were 377,708 shares as of 2021-09-30.

Added: BELLUS Health Inc (BLU)

Tri Locum Partners LP added to a holding in BELLUS Health Inc by 159.11%. The purchase prices were between $2.7 and $6.64, with an estimated average price of $3.78. The stock is now traded at around $6.420000. The impact to a portfolio due to this purchase was 1.46%. The holding were 972,997 shares as of 2021-09-30.

Added: Eagle Pharmaceuticals Inc (EGRX)

Tri Locum Partners LP added to a holding in Eagle Pharmaceuticals Inc by 29.06%. The purchase prices were between $43.79 and $55.78, with an estimated average price of $49.16. The stock is now traded at around $50.860000. The impact to a portfolio due to this purchase was 0.61%. The holding were 122,503 shares as of 2021-09-30.

Added: Cyclacel Pharmaceuticals Inc (CYCC)

Tri Locum Partners LP added to a holding in Cyclacel Pharmaceuticals Inc by 66.90%. The purchase prices were between $4.54 and $6.02, with an estimated average price of $5.36. The stock is now traded at around $4.780000. The impact to a portfolio due to this purchase was 0.44%. The holding were 522,943 shares as of 2021-09-30.

Sold Out: Jazz Pharmaceuticals PLC (JAZZ)

Tri Locum Partners LP sold out a holding in Jazz Pharmaceuticals PLC. The sale prices were between $128.64 and $184.79, with an estimated average price of $151.34.

Sold Out: Protagonist Therapeutics Inc (PTGX)

Tri Locum Partners LP sold out a holding in Protagonist Therapeutics Inc. The sale prices were between $12.95 and $49.69, with an estimated average price of $42.78.

Sold Out: Johnson & Johnson (JNJ)

Tri Locum Partners LP sold out a holding in Johnson & Johnson. The sale prices were between $161.5 and $179.47, with an estimated average price of $170.65.

Sold Out: Cigna Corp (CI)

Tri Locum Partners LP sold out a holding in Cigna Corp. The sale prices were between $200.16 and $238.3, with an estimated average price of $217.75.

Sold Out: Aldeyra Therapeutics Inc (ALDX)

Tri Locum Partners LP sold out a holding in Aldeyra Therapeutics Inc. The sale prices were between $7.94 and $11.31, with an estimated average price of $9.2.

Sold Out: Pfizer Inc (PFE)

Tri Locum Partners LP sold out a holding in Pfizer Inc. The sale prices were between $39.25 and $50.42, with an estimated average price of $44.27.



Here is the complete portfolio of Tri Locum Partners LP. Also check out:

1. Tri Locum Partners LP's Undervalued Stocks
2. Tri Locum Partners LP's Top Growth Companies, and
3. Tri Locum Partners LP's High Yield stocks
4. Stocks that Tri Locum Partners LP keeps buying
Rating:
NaN / 5 ( votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles

Q&A with Gurus